InvestorsHub Logo
Followers 40
Posts 6587
Boards Moderated 0
Alias Born 11/16/2003

Re: runncoach post# 16223

Wednesday, 07/29/2020 9:51:38 PM

Wednesday, July 29, 2020 9:51:38 PM

Post# of 21544
SEC filing a/h today,that's why:
https://www.sec.gov/Archives/edgar/data/1513856/000110465920087851/tm2025275-1_8k.htm

On July 23, 2020, Neurotrope BioScience, Inc. (“Neurotrope BioScience”), a wholly-owned consolidated operating subsidiary of Neurotrope, Inc. (“Neurotrope”), executed a Services Agreement (the “Agreement”) with Worldwide Clinical Trials, Inc. (together with its affiliates, “WCT”). The Agreement relates to services for Neurotrope BioScience’s Phase 2 clinical study assessing the safety, tolerability and long-term efficacy of bryostatin in the treatment of moderately severe Alzheimer’s disease subjects not receiving memantine treatment (the “Study”).

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNPX News